Genetics
FDA Approves Larotrectinib for NTRK+ Cancers
BY JASON M. BRODERICK
Understanding Multigene Testing for Breast Cancer
BY MARY ALISON SMANIA, DNP, FNP-BC, AGN-BC, FAANP
To Test or Not to Test? Pros, Cons, and the Promise of Genomics in Prostate Cancer
BY ELLEN RICE TICHICH, MFA, MSN, RN-BC
Broad-Based Genomic Sequencing May Not Improve Survival in Patients with Lung Cancer
BY JESSICA SKARZYNSKI
How to Advise Patients About Direct-to-Consumer Genetic Testing
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Surprise, You Are Adopted
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Benefits and Risks of Direct to Consumer Genetic Testing for Cancer
BY SUZANNE M. MAHON RN, DNSC, AOCN, AGN-BC
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.